Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Annona muricata leaf extract is a botanical product derived from the tropical plant *Annona muricata*, commonly known as graviola, soursop, or guanabana. The extract is rich in bioactive annonaceous acetogenins, most notably annonacin, which are thought to exert anticancer effects by inducing the intrinsic apoptotic pathway in malignant cells. It is currently being evaluated in a Phase 1 open-label pilot study in Australia, sponsored by the Sydney Local Health District and Concord Repatriation General Hospital, to assess its safety and tolerability in patients with metastatic or recurrent Stage III/IV cancers who are not undergoing concurrent chemotherapy. The product used in clinical research is a commercially available dietary supplement manufactured by Swanson Health Products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on annona muricata leaf extract.